Stock analysis on net
Export to Excel Export to OpenOffice.org Print

Novartis AG (NVS) | Profitability Analysis

Profitability ratios measure the company's ability to generate profitable sales from its resources (assets).


Ratios (Summary)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Novartis AG, profitability ratios

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Return on Sales
Gross profit margin % % % % %
Operating profit margin % % % % %
Net profit margin % % % % %
  Return on Investment
Return on equity (ROE) % % % % %
Return on assets (ROA) % % % % %

Source: Based on data from Novartis AG Annual Reports

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Novartis AG's gross profit margin deteriorated from 2010 to 2011 and from 2011 to 2012.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Novartis AG's operating profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Novartis AG's net profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012.
ROE A profitability ratio calculated as net income divided by shareholders' equity. Novartis AG's ROE deteriorated from 2010 to 2011 and from 2011 to 2012.
ROA A profitability ratio calculated as net income divided by total assets. Novartis AG's ROA deteriorated from 2010 to 2011 and from 2011 to 2012.

Gross Profit Margin

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Gross profit
Net sales
   
Gross profit margin1 % % % % %

Source: Based on data from Novartis AG Annual Reports

2012 Calculations

1 Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × ÷ = %

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Novartis AG's gross profit margin deteriorated from 2010 to 2011 and from 2011 to 2012.

Operating Profit Margin

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Operating income
Net sales
  Operating Profit Margin, Comparison to Industry
Novartis AG1 % % % % %
  Industry, Health Care % % % % %

Source: Based on data from Novartis AG Annual Reports

2012 Calculations

1 Operating profit margin = 100 × Operating income ÷ Net sales
= 100 × ÷ = %

Ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Novartis AG's operating profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012.

Net Profit Margin

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Net income attributable to shareholders of Novartis AG
Net sales
  Net Profit Margin, Comparison to Industry
Novartis AG1 % % % % %
  Industry, Health Care % % % % %

Source: Based on data from Novartis AG Annual Reports

2012 Calculations

1 Net profit margin = 100 × Net income attributable to shareholders of Novartis AG ÷ Net sales
= 100 × ÷ = %

Ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Novartis AG's net profit margin deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012.

Return on Equity (ROE)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Net income attributable to shareholders of Novartis AG
Issued share capital and reserves attributable to Novartis AG shareholders
  ROE, Comparison to Industry
Novartis AG1 % % % % %
  Industry, Health Care % % % % %

Source: Based on data from Novartis AG Annual Reports

2012 Calculations

1 ROE = 100 × Net income attributable to shareholders of Novartis AG ÷ Issued share capital and reserves attributable to Novartis AG shareholders
= 100 × ÷ = %

Ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders' equity. Novartis AG's ROE deteriorated from 2010 to 2011 and from 2011 to 2012.

Return on Assets (ROA)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Net income attributable to shareholders of Novartis AG
Total assets
  ROA, Comparison to Industry
Novartis AG1 % % % % %
  Industry, Health Care % % % % %

Source: Based on data from Novartis AG Annual Reports

2012 Calculations

1 ROA = 100 × Net income attributable to shareholders of Novartis AG ÷ Total assets
= 100 × ÷ = %

Ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Novartis AG's ROA deteriorated from 2010 to 2011 and from 2011 to 2012.